Skip to content

Effects of AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Males Exposed by Ultraviolet in Daily Life

Effects of AVGP (Aloe Vera Gel Powder) for Skin Function of Adult Males Exposed by Ultraviolet in Daily Life - Effects of AVGP (Aloe Vera Gel Powder) for Skin Function

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
JPRN
Registry ID
JPRN-UMIN000018384
Enrollment
48
Registered
2015-07-23
Start date
2015-07-25
Completion date
Unknown
Last updated
2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Skin function

Interventions

Sponsors

TES Holdings Co., Ltd
Lead Sponsor
Department of Dermatology, Wakayama Medical University
Collaborator

Eligibility

Sex/Gender
Male

Inclusion criteria

Inclusion criteria: [1]Healthy Japanese males aged 30-60 years [2]Individuals who are outside in the daytime for 2-5 hours

Exclusion criteria

Exclusion criteria: [1]Individuals who use regularly cosmetology or foods affecting to skin condition [2]Individuals who have skin disease [3]Individuals whose arm(s) have an abnormality requiring treatment [4]Individuals who use regularly quasi-drugs, cosmetics, and creams [5]Individuals who tan regularly at a tanning salon [6]Individuals who contract allergic disease with sleep deprivation or sleep disorder [7]Individuals who contract disease affecting to skin condition [8]Individuals who excessively take alcohol (expressed in an amount of alcohol: over 60mg/day) [9]Individuals who is a smoker (smoking over 20 cigarettes/day) [10]Individuals who contract or have a history of serious skin disease, hepatopathy, kidney damage, heart disease, lung disease, endocrine disease, and metabolic disease [11]Individuals who have a history of drug allergy or serious food allergy [12]Individuals who participated in other clinical studies in the past three months [13]Individuals judged inappropriate for the study by the principal by the results of subject background, physical findings, or medical examination

Design outcomes

Primary

MeasureTime frame
[1]Skin viscoelasticity [2]Transepidermal water loss [3]Water content of the skin [4]Collagen score (measuring with ultrasonic waves)

Secondary

MeasureTime frame
[1]Observation for skin condition [2]Subjective symptom for skin condition

Countries

Japan

Contacts

Public ContactToshiyasu Tamura

TES Holdings Co., Ltd Department of Clinical Trial

info@tes-h.co.jp03-6801-8480

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026